GlassScriptPhysician profile
Angela Baker
NPI 1992173173
$6,812.11
in general payments reported to CMS, 2019-2025
18 companies · $1,481 in 2025
The $1,481 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $425 · 2022: $2,639 · 2023: $547 · 2024: $1,720 · 2025: $1,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,945 · Travel and Lodging: $1,802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,945.42 |
| Travel and Lodging | $1,802.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,880.41 | 2021-2022 | |
| Boston Scientific Corporation | $1,782.15 | 2021-2025 | Watchman, Watchman Access System, S-Icd System Magnet |
| Atricure, INC. | $1,732.45 | 2021-2025 | Synergy Ablation System |
| Abbott Laboratories | $376.94 | 2021-2024 | Cardiomems, Amplatzer Amulet |
| E.R. Squibb & Sons, L.L.C. | $217.84 | 2021-2025 | Camzyos |
| Abiomed | $212.41 | 2025 | |
| Biosense Webster, INC. | $122.16 | 2022-2025 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $116.32 | 2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.00 | 2022 | |
| Elutia, INC. | $43.88 | 2023 | |
| Novartis Pharmaceuticals Corporation | $43.70 | 2023 | |
| Janssen Pharmaceuticals, INC | $42.49 | 2023 | Xarelto |
| Irhythm Technologies, INC. | $35.63 | 2023 | Zio Xt Patch |
| Tolmar, INC. | $27.09 | 2025 | Eligard, Jatenzo |
| Recor Medical INC | $24.93 | 2024 | Paradise Renal Denervation System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $21.03 | 2022 | |
| Convatec INC. | $16.18 | 2024 | |
| Sanofi-Aventis U.S. LLC | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.